Longevity in Singapore: Why Healthspan Matters More Than Lifespan

Singapore is officially a super-aged society. More than one in five residents are now 65 or older, and the Ministry of Health projects that figure will reach one in four by 2030.¹ By the same year, the retirement age will rise to 65 and re-employment will extend to 70.² Workforces will be older, and for longer, than most benefits programmes were designed to handle.

The health picture compounds the demographic one. Fullerton Health’s own screening data shows steady year-on-year increases in diabetes, hypertension, and hyperlipidemia from 2021 to 2025.

These are not conditions people retire into; they are arriving earlier and staying longer. For Human Resource leaders and CFOs, this trajectory has direct implications: rising claims, eroding productivity, and a workforce carrying unmanaged chronic risk into its most active working years.

The question facing Singapore’s employers is no longer whether to invest in workforce health. It is whether that investment points in the right direction. Most corporate health programmes still operate on a reactive model — built to process claims, not prevent them. That model is increasingly expensive and increasingly inadequate.

The conversation in Singapore has shifted. The frame is no longer just lifespan — how long employees live. It is healthspan: how many of those years are spent in genuine functional health. That distinction has real consequences for how organisations design their benefits, manage their healthcare partners, and plan for the workforce decade ahead.

Healthspan vs. lifespan: why the distinction matters for employers

Lifespan is the number of years a person lives. Healthspan is the number of those years spent in good physical and cognitive health; working at full capacity, free from chronic disease burden.

In Singapore, the gap between the two is significant and measurable. Life expectancy at birth reached 83.9 years in 2025 according to SingStat.³

The World Health Organization puts Singapore’s healthy life expectancy at 73.6 years in 2021.⁴ That leaves nearly a decade, on average, when most people are managing chronic disease, reduced mobility, or cognitive decline.

There are three forces moving healthspan from a wellness concept into a business priority.

Longevity science is maturing; the evidence base for early detection, biomarker-led risk stratification, and precision-matched interventions is stronger than it has ever been.
Benefits design is shifting; employers are asking not what programmes they offer, but what those programmes actually achieve.
Demand from employees is measurable and rising, post-pandemic. Individuals are taking more initiative on preventive health, and they increasingly factor healthcare quality into where they choose to work.

For Singapore, the opportunity is structural. Strong primary care infrastructure, an engaged employer market, and the momentum behind HealthierSG create conditions that do not exist in most other markets in the region. The question is whether organisations move early or wait until chronic cost pressure forces the issue.

From reactive treatment to proactive prevention: how the model is changing

The conventional employer healthcare model is built around what happens after something goes wrong. Employees access a GP panel when they are ill. Claims are processed through a Third-party Administrator (TPA). Specialist referrals are triggered by acute events, hospitalisation is covered, and a system where it is designed to respond to illness, not to stop it from happening

The proactive model works differently. Risk is identified through regular, structured screening before symptoms appear. Chronic conditions are caught earlier, when management options are broader and less expensive. Care is personalised to individual risk profiles rather than applied uniformly across a workforce, and outcomes data flows back to HR and leadership, so the investment is measurable.

Policy is moving in the same direction. Healthier SG pairs every resident with a regular family doctor and reorients the healthcare system toward long-term health goals rather than episodic treatment. Screening technologies that were previously hospital-grade, such as advanced biomarker panels, biological-age assessments, and cardiovascular risk stratification, are increasingly available through primary care settings. The infrastructure for prevention is being built at a national level; the question for employers is whether their benefits programmes are aligned with it.

According to Dr Morrison Loh, Group Chief Strategy Officer & Group Chief Commercial Officer at Fullerton Health,

"Chronic diseases that weren't as prevalent in previous generations are becoming a significant health problem now, such as hypertension and cholesterol appearing earlier in life. The best way to manage the entire healthcare cost equation is prevention. That means more structured screening, lifestyle support, dietary guidance — and then using the healthcare data collected to advise companies ways to improve employee health outcomes over time.”

The practical gap for most employers is awareness and execution. Knowing that prevention is more cost-effective than treatment is one thing. Building a programme that delivers it, at scale, across a diverse workforce, is another. That requires a healthcare partner operating across the full continuum: from screening and primary care through to chronic disease management, mental health, and specialist access. A fragmented set of vendors, each managing a narrow slice of the picture, cannot deliver the data integration or the care continuity that a proactive model demands.

What the data is telling employers

The cost case for preventive care is no longer theoretical. Mental health conditions alone cost the Singapore economy an estimated S$15.7 billion annually⁵ — approximately 2.9% of GDP — with most of that loss attributable to presenteeism rather than absence. Employees showing up to work while managing untreated mental health conditions represent a productivity loss that claims data does not capture, which means most organisations are systematically underestimating their true exposure.

Medical cost inflation compounds the picture. Aon’s 2026 Global Medical Trend Rates Report shows Asia Pacific facing double-digit medical inflation, and Singapore is not sheltered from that pressure.⁶

The trajectory on younger workers is particularly stark: obesity among adults aged 18 to 29 has increased significantly, and one in four young adults now reports poor mental health.⁷ These are not distant actuarial projections. They describe the workforce that organisations are hiring today.

“Companies are under real pressure. Medical costs are climbing, and management is being asked to provide proper health coverage while keeping it within a cost ceiling. At the same time, employees factor health benefits into where they choose to work; they want to know the company will take care of them if they’re unwell. So the company wants to manage absenteeism, process claims efficiently and give staff confidence that their health is taken seriously. That’s where we come in,”

Derrick Chan, Managing Director (Singapore and Malaysia) at Fullerton Health.

The answer most organisations reach for — tightening the cost ceiling on their existing programme — addresses the symptom rather than the cause. Reactive programmes cost more over time because they wait for conditions to become expensive before intervening. The organisations that will manage healthcare costs most effectively over the next decade are those that shift the balance: more investment upstream in prevention and early detection, less downstream in high-cost acute and specialist claims.

What good looks like: the integrated model

The shift from reactive to proactive is a structural change and requires healthcare programmes that are built differently from the ground up.

In practice, that means structured screening tied to genuine clinical follow-up, rather than just a once-a-year biometric event with no continuity of care. It means chronic disease management pathways for employees who need them, integrated with clinical services rather than sitting separately from them. And data — utilisation trends, cost forecasting, population health indicators — that flow to HR and leadership in a form that enables real decision-making.

The decade ahead: what employers should be preparing for

Several directions are clear enough to plan around now.

Health programmes will become more personalised, built around the individual instead of a standard package. The boundary between national primary care and employer-sponsored benefits will continue to dissolve. HealthierSG is designed to bring every resident into regular contact with a family doctor focused on long-term health goals. Employers whose programmes align with that infrastructure, rather than running parallel to it, will get more value from both.

Biomarkers and wearable data will shift from optional to expected. Blood-based risk markers, continuous health monitoring, and biological-age assessments are no longer specialist interventions. They are becoming part of how risk is identified and managed at the population level. Employers that build these inputs into their programmes now will have a meaningful advantage in managing long-term healthcare costs.

And as the evidence base for prevention matures, the investment case will become easier to make. Years of structured outcomes data — linking upstream investment in screening and chronic management to downstream reductions in acute claims — will give CFOs and boards the numbers they need to justify a different allocation.

Singapore is well placed for this transition. The policy environment, the clinical infrastructure, and employer engagement are aligned in a way that does not exist in most other markets. The organisations that move now — building integrated programmes, selecting partners who operate across the full care continuum, and measuring outcomes rather than activity, will be the ones that look back in ten years and realise they got ahead of the problem.

Healthspan is a regional opportunity. The winners will be the partners and the employers who treat longevity as a strategic priority, not a cost line.

That’s what Fullerton Health is built for, across Singapore and the wider region.

References: